1. Introduction {#sec1}
===============

Early life stress exposure has a significant impact on later behavior and has been associated with a number of clinical disorders. Notwithstanding, early life stress exposure has been associated with anxiety, depression, drug abuse, and schizophrenia. The effects of early stress exposure emerge later in adolescence. The following review examines the inter-relationships between early life stress exposure, addiction, and the mediating factors that have received less attention. Namely, arousal, inflammation, and the timing of stress exposure are discussed within a sensitive period framework. During a sensitive period, low levels of GABA and BDNF maintain a high state of plasticity, implying a state of immaturity. Preventative interventions given during a sensitive period may reduce later appearing abnormalities.

Developmental exposure to toxic stress has been found in 54% of the addiction population. Toxic stress includes physical/sexual abuse, neglect, loss of a caregiver, and exposure to a dysfunctional household (e.g. domestic violence, exposure to drug use, or exposure to a natural disaster). Epidemiology studies show that exposure to early life adversity increases vulnerability to a number of disorders that include affective and reward dysfunction (e.g., addiction, depression, schizophrenia) in a sex-dependent manner ([@bib50]). Stress exposure can be quantified with the Adverse Childhood Experiences scale (ACEs) ([@bib4]), which has helped to standardize the field. Increases in the number of ACEs are associated the risk of addiction in general ([@bib70]). For example, more than four ACES increase the risk of addiction 7--10 fold ([@bib70]). The impact of these statistics lies in the relationship between the ages of initiation of drug use. Specifically, more ACES are associated with increased risk of initiating drug use early (\<14 years of age) by 2--4 fold ([@bib70]). Significant abuse (molestation and abuse) resulted in odds ratios of 3.5 for alcohol/cigarette experimentation and 12.2 for marijuana use/regular drinking by age 10 ([@bib19]). While a number of risk factors for addiction are associated with stress, early initiation of drug use (possibly the consequence of these risk factors ([@bib129])) increases the chance of lifelong addiction by 4--10 fold across different drug classes ([@bib174]; [@bib261]).

Developmental maltreatment in animals is experimentally produced in a number of ways. Early life stress paradigms include maternal separation, deprivation, or early weaning. How these different animal stress paradigms compare to the human condition is dicussed in ([@bib6]). The naturalistic model of early stress exposure categorizes the dam as having low or high licking and grooming behavior (low/high-LG; ([@bib37]; [@bib44]). High-LG is beneficial to the rat pup, while low LG is stressful. The experimental approach involves isolating pups from the dam and/or littermates for as little as 24 h ([@bib155]) to an average of 2--6 h a day and between the ages of P2-20 depending on individual investigators ([@bib149]; [@bib207]; [@bib212]). Pups and dam are reunited after the separation. This separation can occur over the stress-hypo responsive period (SHRP), when stress responsiveness is low due to increased GABA effects on the hypothalamic-pituitary-adrenal axis ([@bib64]). The SHRP programs reduced corticosterone levels ([@bib217]) and may provide a period of increased plasticity that is found in other systems (i.e., visual processing ([@bib82])). Maternal separation or neonatal separation has revealed important and persistent changes in neuroanatomy, neurochemistry, and behavior ([@bib8]; [@bib10]; [@bib170]; [@bib176]). Together, the maternal separation paradigm provides a species-relevant, early life stressor that yields similar changes in brain morphometry and behavior to those observed in child abuse ([@bib6]; [@bib244]).

2. Stress and the role of externalizing and internalizing behaviors in addiction {#sec2}
================================================================================

Broadly conceptualized as externalizing and internalizing disorders ([@bib241]), this nosology has been used to identify latent correlations with drug use ([@bib139]). There is tremendous overlap between externalizing and internalizing disorders that are linked to dysfunctional reward and affect processing. The timing of stress exposure may differentially shape individuals to be vulnerable to substance use (see Section [3](#sec3){ref-type="sec"}). A number of outcomes are possible following exposure to early life stress (reviewed by ([@bib48]; [@bib251])).

2.1. Clinical {#sec2.1}
-------------

While a number of studies suggest that early life stress increases risk for substance use ([@bib45]; [@bib265]), this relationship is complex. Inconsistencies in the persistence of drug use suggest that mediating or moderating variables play a significant role in drug abuse vulnerability in a maltreated population ([@bib87]; [@bib268]). A recent longitudinal study conducted between the ages of 14--17 years in a maltreated population found that externalizing symptoms and substance use persist across this timeframe, whereas the relationship between internalizing symptoms and drug use does not ([@bib268]). Together, these studies (and those below) raise the question regarding what are the other mediating/moderating factors that underlie the relationship between abuse and drug abuse.

Externalizing disorders include attention deficit hyperactivity disorder (ADHD), oppositional defiant disorder, and conduct disorder. These disorders are characterized by oppositional, aggressive, impulsive, disruptive, and rule-breaking behavior and are further associated with poor social interactions. Overall, individual externalizing behaviors are often part of a trajectory of more serious illness ([@bib271]). For example, exposure to early childhood adversity is associated with a greater likelihood of a substance use disorder, incarceration, and early pregnancy later in life ([@bib9]; [@bib21]; [@bib53]; [@bib67]; [@bib76]; [@bib238]). Physically aggressive behavior is more predominant in males than in females with conduct disorder ([@bib51]). Early pregnancy is common in girls with conduct disorder ([@bib53]; [@bib238]). Specifically, childhood maltreatment in girls is associated with increased sexual activity and a 66% higher chance of teen pregnancy ([@bib76]; [@bib97]; [@bib137]). Over 50% of individuals diagnosed with conduct disorder meet criteria for a substance use disorder ([@bib211]). In fact, a diagnosis of conduct disorder between 11 and 14 years of age predicts substance use disorders by 18 years of age (all odds ratios, \> 4.27) ([@bib76]; [@bib240]). Externalizing disorders are more strongly associated with alcohol use disorder than internalizing disorders ([@bib85]).

Internalizing disorders include anxiety and depression ([@bib241]). Both anxiety and depression have their own individual developmental trajectories of impairment, although anxiety often precedes depression ([@bib14]). Anxiety disorders are more prevalent in individuals with higher ACES. The prevalence of depression is ∼67% of an early life stress population ([@bib10]; [@bib243]; [@bib264]) compared to a lifetime prevalence of ∼20% in the general population ([@bib138]). Like externalizing disorders, poor social interactions often lead to isolation ([@bib271]). The presence of an internalizing disorder meditates the effects of early child neglect and later substance use ([@bib69]; [@bib73]). Specifically, early sexual abuse in females is associated with greater risk for alcohol abuse and/or dependence in adulthood as determined in a cross-sectional study ([@bib178]) as well as a longitudinal study ([@bib231]). Early life stress affects both genders at the level of internalizing behaviors, whereas externalizing disorders are more prevalent in males.

2.2. Preclinical {#sec2.2}
----------------

Exposure to early life stress increases both externalizing and internalizing behaviors ([@bib167]) that are risk factors for drug use. The presence of behavioral disinhibition as discussed above characterizes symptoms of externalizing behaviors in animals ([@bib90]). Early stressed animals demonstrate more impulsivity than controls ([@bib103]). Maternally separated rats have increased levels of aggression ([@bib109]; [@bib259]) that is mediated by impaired social recognition ([@bib158]). Males of low-LG dams ([@bib200]) or following maternal separation ([@bib109]) have increased aggressive play behavior relative to controls. Females show greater aggressive play strategies when low-LG rats are compared to high-LG counterparts (and not control rats ([@bib199])). In females, but not males, low-LG programs reproductive success ([@bib38]). Low-LG females also demonstrate precocial puberty and are more sexually receptive relative to high-LG females ([@bib39]; [@bib250]). Elevated estrogen increases aggression in females probably due to its aromatization to testosterone ([@bib276]). Testosterone is able to moderate the effects of high- and low-LG on sexual receptivity of females with a maternal separation history ([@bib25]).

Early stress increases responses to stimulants. Male mice show hypersensitive stress responses to the locomotor effects of low doses of cocaine ([@bib140]). However, discrepancies exist as to whether male rats exposed to maternal separation show increased stimulant intake ([@bib143]l; [@bib254]) or show no change ([@bib169]). Female rats separated for 60 min between P2-9 acquire cocaine self-administration more rapidly than controls ([@bib144]) that are independent of estrogen-mediated increases in self-administration ([@bib145]). Separated females also show increased sensitivity to cocaine relative to separated males and controls ([@bib171]), but show lower baseline responding on a progressive ratio schedule for intracranial self-stimulation relative to controls ([@bib179]). Curiously, locomotor responses to amphetamine are evident in maternally separated animals when they are in a novel, but not habituated, environment ([@bib117]). These data raise the possibility that increased susceptibility to drug use (e.g., stimulants) occurs under stressful conditions in early stressed animals.

Internalizing behaviors of depressive-like effects have been observed in animals. Exposure to early life stress in animals is associated with elevated anxiety-like behaviors ([@bib155] \#86} and depressive-like behaviors ([@bib6]). Both of these behaviors are common to addiction and are sex-dependent. For example, elevated alcohol intake is observed in males exposed to early life stress (separation between P1-20 for 6 h/day), with little to no effect in stressed females in adulthood ([@bib213]). Alcohol consumption reduces the anhedonic effects of alcohol withdrawal in adolescent rats ([@bib26]). However, maternal separation (P2-20 for 4 h/day) increases anhedonia during adolescence in females, but not males ([@bib153]; [@bib160]). These sex differences could result from different durations in stress exposures or the age of assessment. Greater alcohol consumption in adolescence is observed in longer separations (360 min) from the dam compared to shorter separations (15 min) ([@bib59]; [@bib127]). Besides anhedonia, chronic pain mediates a relationship between a history of child abuse and depression in humans ([@bib102]). It should be no surprise that maternally separated animals, who have a high rate of depression, show a 78% progressive decrease in morphine aversion ([@bib258]) and place preferences for morphine and increased intake ([@bib258]).

Mechanistic changes that underlie behavioral changes are reviewed elsewhere. A brief review of predisposing factors that are relevant to drug-taking can be found in ([@bib182]). Relatedly, dopamine (Flagel et al.),2010) and opiate changes ([@bib206]) following maternal separation are reviewed. Finally, the genetic basis underlying vulnerability to the adverse effects of stress can be found in ([@bib233]).

2.3. Integration of clinical and preclinical findings {#sec2.3}
-----------------------------------------------------

Drug choice amongst humans or animals reflects whether they exhibit externalizing or internalizing behaviors, although there is overlap. In both humans and animals, deficits in executive function including the regulation of affect and reward are involved in risk behaviors. Behaviors such as aggression, impulsivity, and poor social function are risk factors for increased substance use and are found in both humans and animals following exposure to early adversity. Other behaviors observed following maltreatment include anhedonia, pain exposure, and anxiety. The inter-relationship between risk behaviors and substance use has been characterized more in association studies in humans than in animals. Animal studies have examined the developmental expression of risk behaviors in early stress models; the relationship between stress, early expression of risk factors *and* subsequent drug use is sorely missing. Understanding how different forms of abuse (physical, sexual, or neglect) or its duration influence risk behavior and subsequent drug-taking may offer insight for preventative treatment.

3. The timing of stress exposures and their relationship to addiction {#sec3}
=====================================================================

The timing of stress exposure is important for regional brain changes that are associated with addiction. Exposure to early life stress accelerates the appearance of behaviors and brain development relative to controls ([@bib99]; [@bib129]). Brain regions that share commonalities between stress exposure and addiction will be presented. Early maturity can lead to earlier initiation of drug use, which in turn, is associated with greater prevalence of lifelong addiction ([@bib174]; [@bib261]). The emergence of addiction requires activity in the prefrontal cortex (and other regions) that regulates, or fails to regulate, behavior.

The timing of stress exposure interacts with a sensitive period to uniquely effect behavior ([@bib10]). Experiences that occur during a sensitive period will have maximal effect on regional brain development to fine-tune neuronal circuits ([@bib5]; [@bib107]). Sensitive periods differ from critical periods, which require specific information to guide development ([@bib107]). The limited time course of development of ocular dominance columns is a classic example of a critical period ([@bib151]). Alternatively, sensitive periods may represent a critical period that occurs during the second phase of synaptic overproduction and elimination. Stress exposure that occurs during active development will permanently alter the course of maturation. As a result, stress during a sensitive period will impact addiction-related behaviors as a function of age. The manifestation of stress-related changes is often delayed until adolescence ([@bib10]).

3.1. Clinical {#sec3.1}
-------------

The caveat for all human studies, unless otherwise noted, is the directionality of the effect. Whether there is existing brain dysfunction prior to the onset of abuse or is the abuse the outcome of the dysfunction can be answered by animal studies. Unfortunately, very few human studies in early maltreated individuals have examined neuroanatomical changes that are relevant to drug use ([@bib62]), and even fewer have characterized the age of abuse onset. Through structural equation modeling, the associations between the age of maltreatment and morphometric MRI changes were determined and believed to reflect times when the region is most sensitive to exposure to adversity ([@bib11]; [@bib201]).

**3.1.2** While estimated ages, reductions in the volume of the hippocampus are associated with abuse occurring between 3 and 5 years of age. Reduced hippocampal function results in less regulation of the hypothalamic-pituitary-adrenal axis that modulates glucocorticoid release and more drug craving ([@bib141]; [@bib260]). Maltreated individuals have reduced hippocampal size ([@bib60]; [@bib237]). Smaller hippocampal volume in alcoholics ([@bib60]) predicts the severity of drug abuse relapse ([@bib253]). In a non-abused population, hippocampal volume correlates positively with the early age of onset of alcohol use ([@bib60]) and negatively with the duration of an alcohol use disorder. Alcohol use disorder has an accelerated age of onset in teens with a history of physical and sexual abuse ([@bib49]).

**3.1.3** Exposure to maltreatment between 10 and 11 years of age has maximal effects on the size of the right amygdala ([@bib201]). It is within this timeframe that exposure to child maltreatment accelerates negative amygdala-prefrontal cortex connectivity causing it to attain maturity earlier than age-matched controls ([@bib99]). Reduced amygdala volume is associated with increased cocaine use in adults ([@bib177]) probably due to its role in forming the associations between drug and formally neutral cues involved in relapse ([@bib223]; [@bib260]).

**3.1.4** The sensitive period for the effects of sexual abuse in the prefrontal cortex occurs between 14 and 16 years of age. The prefrontal cortex plays a significant role in reward valuation and regulating risky behaviors. For example, the prefrontal cortex modulates impulsivity, novelty preferences, and responses to drug-associated cues in humans ([@bib42]). Together, the timing of maltreatment is associated with selective vulnerability of brain regions. The timing of maltreatment results in different behavioral outcomes that include addiction. Personalized scripts that are read during an fMRI assessment determine activation (or deactivation) responses to drug-associated cues. Cocaine-dependent men with a history of childhood maltreatment have increased left dorsolateral prefrontal cortex activation in response to drug cues and decreased regulatory processes compared with cocaine-dependent men without abuse ([@bib78]).

3.2. Preclinical {#sec3.2}
----------------

Animal studies enable the study of timing of stress exposure as it relates to the onset of drug addiction. Of equal importance, the maturation of the brain after the stress experience interacts with the original experience to delay or accelerate the emergence of drug addiction. A number of brain regions that are affected by early stress are associated with delayed outcomes. The majority of subjects in early stress models are tested in adulthood and not immediately after the end of their stress exposure. As a result we know the endpoint of stress exposure, but little about the process across age. Finally, the direct relationship between the brain area and addiction-related behavior has not been assessed as directly as those found in human MRI studies.

**3.2.1** The expression of synaptophysin, a measure of synaptic density, in the hippocampus in rats exposed to maternal separation (4 h/day P2-20) fails to undergo normal overexpression of synapses during adolescence relative to control rats ([@bib8]). Chronic cold stress (4° between P7-27) in mice decreased hippocampal expression of glutamate-related proteins of the excitatory amino-acid transporter-3 (EAAT-3), the glial glutamate transporter-1 (GLT-1) and increased glutamate aspartate transporter (GLAST) levels ([@bib194]). These stressed mice also had greater alcohol consumption. Overall, the effect of early stress on the hippocampus as it relates directly to addictive behaviors is minimally characterized.

**3.2.2** The amygdala is involved in anxiety responses that increase reward value via negative reinforcement ([@bib12]). Rats exposed to maternal separation are anxious. They spend more time in the closed arm of the elevated plus maze and show greater preferences for alcohol ([@bib127]; [@bib136]). Alcohol consumption is negatively associated with Pro-opiomelanocortin (POMC) expression in the amygdala in maternally separated (360 min/day) rats ([@bib105]).

**3.2.3** Synaptic density in the prefrontal cortex is not significantly affected by maternal separation until adulthood in the rat ([@bib8]). No age differences were observed in synaptophysin between maternally separated males and age-matched controls between the ages of P20-80. A 16% increase in synpatophysin was observed at P100 in the maternally separated rats. The prefrontal cortex is involved in the risk behavior of impulsivity ([@bib57]; [@bib234]; [@bib236]; [@bib269]). Glutamatergic projections from the dorsal prefrontal cortex to the accumbens core are necessary for the expression of behavioral sensitization to cocaine ([@bib204]). The dopamine D1 receptor in the prefrontal cortex is important for motivational effects of drug-related cues ([@bib263]). The D1 receptor is overproduced on glutamatergic projects from the prefrontal cortex to the accumbens in normal animals ([@bib32]), but reduced in animals that were maternally separated ([@bib30]). The decrease in D1 receptors on glutamatergic afferents is associated with anhedonia ([@bib92]), a risk factor for addictive behaviors. Maternally separated animals tested in a dark-cold living conditions as adults exhibit reduced motivation to obtain sucrose in a progressive ratio schedule ([@bib216]).

While the majority of studies fail to find changes in motivational properties of cocaine cues following early life stress (e.g. ([@bib170]),), one possibility is that an adolescent stressor is needed to produce prefrontal cortex mediated effects. Decreased cortical activity or volume is observed in both abused humans ([@bib10]) and in adolescent rats that underwent social isolation ([@bib108]; [@bib154]). Investigations show that later stress increases addictive behaviors that are associated with cortical function. Adolescent stress models include social isolation and social defeat stress. As an example, rats that were isolation reared as adolescents, but not maternally deprived, show locomotor sensitization to intermittent 1.5 mg/kg of amphetamine ([@bib180]). Notably, early stress rats will initiate drug use earlier than controls due to the influence of accelerated development of the other brain regions influencing the development of the prefrontal cortex.

3.3. Integration of clinical and preclinical findings {#sec3.3}
-----------------------------------------------------

Sensitive periods and their relationship to early stress exposure and drug use open the window to a relatively new approach to treatment. By knowing the age of the stress exposure, the promise of sensitive periods lies in the optimal time for intervention and possibly, the type of drug to target addiction. Clinical investigations have not paid enough attention to the age of abuse; preclinical studies have missed the opportunity to determine relationships between age, duration, and type of stressor and how they influence risk behaviors and subsequent drug use. Both clinical and preclinical studies have similar decreases in hippocampal volume and adolescent effects of stress in the prefrontal cortex. Stress-induced increases in drug-taking will emerge once the cortex reaches a threshold level of maturity. Complementary clinical and preclinical studies can determine whether stress-induced brain changes are a cause or consequence of stress and how perturbation of one region can effect the development of another.

4. Mechanisms of sensitive periods of stress exposure {#sec4}
=====================================================

Critical/sensitive periods are defined by changes in growth factors, such as brain-derived growth factor (BDNF; or its receptor, tropomyosin receptor kinase B \[TrkB\]), and the GABAergic fast-spiking interneuron that expresses the calcium-binding protein of parvalbumin (PV) ([@bib126]; [@bib185]). A decrease in these factors signals the initiation of a sensitive period. Decreased inhibition allows excitatory activity to shape the development of synapses ([@bib246]) and in essence, tips the balance towards more excitatory activity. Elevated glutamatergic activity is associated with more dendritic branching, increased signaling, and general plasticity. This glutamatergic overproduction is followed by pruning and a rise of PV and BDNF/TrkB levels. Together low excitatory and higher inhibition that closes the sensitive period resulting in less plasticity. The final stage occurs when perineuronal nets (PNNs) surround the PV neurons, thus protecting the synapse and consolidating the information ([@bib273]).

In addition, increases in the GABA-Aα1 receptor subtype close sensitive periods in concert with rising PV levels, as exemplified by changes in the visual system ([@bib81]; [@bib82]). GABA-Aα1 receptors are fast-acting ionotropic receptors. Similarly, both PV and GABA-Aa1 rise in concert in the non-human primate PFC ([@bib123]). GABA-A levels are reduced in the amygdala of adult MS subjects ([@bib36]), although the age that this first occurs is not known. Injections of the GABA-Aa1 agonist muscimol into the amygdala are associated with more anxiety-like behavior ([@bib210]).

4.1. The role of GABA and BDNF in externalizing and internalizing behaviors {#sec4.1}
---------------------------------------------------------------------------

### 4.1.1. Clinical {#sec4.1.1}

Both GABA and BDNF are involved in developmental plasticity that shapes the trajectory of brain development (discussed in more detail below). The results from studies that examine GABA and behavior are dependent on which region of the brain was examined. For an excellent review of GABA changes and impulsivity, see ([@bib112]). Generally, low GABA levels (as measured with magnetic resonance spectroscopy) characterize externalizing behaviors. Low cortical GABA is found in individuals characterized as having a more cognitive impulsive phenotype (versus motor impulsivity ([@bib228])), aggressive behavior ([@bib79]), and reduced fear-associated behavior ([@bib189]). However, increased GABA levels have been reported in conduct disorder ([@bib58]). Elevated impulsivity in borderline personality disorder and ADHD were associated with elevated cortical GABA ([@bib79]). Changes in BDNF levels are found in individuals with addiction ([@bib46]).

### 4.1.2. Preclinical {#sec4.1.2}

Adult rats characterized as highly impulsive with the 5-choice serial reaction task (a task of motor impulsivity) have lower GABA-Aα1 receptor binding in the anterior cingulate cortex, thus disinhibiting outgoing activity ([@bib133]). Similarly, infusions of muscimol, a GABA-Aα1 agonist into the infralimbic prefrontal cortex ([@bib187]) and the prelimbic region ([@bib86]) increased impulsivity. Synthesis inhibition of GABA in the medial prefrontal cortex increases impulsivity ([@bib196]). In contrast, increased GAD-67 expression in the nucleus accumbens is lower in impulsive rats ([@bib40]; [@bib218]). Aggressive behavior in rodents is characterized by low GABA levels measured with ^1^H-MRS GABA (a 40% decrease) in the ventral anterior cingulate cortex ([@bib130]) and measured directly in the lateral hypothalamus ([@bib109]). Other drug abuse risk behaviors (novelty preferences, social deficits) are enhanced by developmental stress exposure and are associated with increased glutamate activity and lower GAD-67 expression ([@bib248]); these results suggest a protracted sensitive period (see below). Changes in GABA that are related to depressive behavior also exist. Both sexes show reduced GABA in teenagers ([@bib93]) and in PV in animals ([@bib29]; [@bib153]; [@bib160]) with anhedonia. Furthermore, TrkB levels correlate with the degree of depressive-like behavior ([@bib159]).

In terms of drug abuse, non-contingent cocaine exposure in adolescent, but not adult, rodents produced an enduring attenuation of medial prefrontal GABAergic activity and PV cell expression, which is postulated to increase the risk of SUD long-term ([@bib43]). This hypothesized increase vulnerability would be further exacerbated by stress-induced losses of PV.

4.2. The role of early life stress in sensitive periods {#sec4.2}
-------------------------------------------------------

### 4.2.1. Parvalbumin changes {#sec4.2.1}

Different types of stress (probably those that are more relevant to the maturational stage) will produce unique effects on behavior and brain development. Exposure to chronic variable stress increases cortical GABA levels ([@bib175]) while social isolation stress has no effect on PV ([@bib160]). Parvalbumin undergoes significant changes during the adolescent period ([@bib33], [@bib34]). Exposure to juvenile stress reduces PV into adulthood, but also alters activity at GABAergic gene promoters including dysregulated DNA methylation, histone modification, and change promoter-enhancer interactions ([@bib186]).

Recent work compared two different stress periods: early life with the maternal separation paradigm and a social isolation paradigm in females only. Previous studies have established that these two stress paradigms produce similar corticosterone levels ([@bib257]). We found that early life stress, but not social isolation, increased anhedonia ([@bib159]). PV and TrkB levels were significantly reduced in the prelimbic cortex following early exposure, whereas adolescent exposure had no effect on these measures. However, social isolation decreased the percentage of PV neurons that were encapsulated by Wisteria floribunda agglutinin (WFA; e.g., perineuronal nets) ([@bib249]). Decreased PV/WFA suggests a vulnerable sensitive period to adolescent stress. Part of this vulnerability may be related to increased reduction-oxidation reactions that might occur following stress exposure during development. To test this hypothesis, mice with glutathoine synthesis gene *Gclm* knock out that produces oxidative stress were examined for changes in PV. Under these re-dox conditions, the dopamine transport blocker GBR-12909 suppressed co-expression of PV and WFA in the cortex ([@bib35]). These data suggest that under conditions of increased oxidative stress, exposure to a stressful challenge (i.e., elevated dopamine in the prefrontal cortex) reduces the perineuronal nets that surround PV neurons, thereby increasing plasticity.

Decreases in PV levels have been associated with reduced working memory in rats exposed to early life stress ([@bib29]) and depressive effects ([@bib153]; [@bib159]). Specifically, levels of anhedonia correlated with PV levels in the prefrontal cortex (r = 0.93; n = 9) in early stress animals, but not controls ([@bib159]). Together, these data are consistent with a prolonged sensitive period where the environment affects cortical plasticity longer than in control animals. Other studies have found that PV loss occurred earlier in female MS rats ([@bib124]), while one study of MS ([@bib224]) failed to find stress-induced changes in PV.

### 4.2.2. Gonadal hormones {#sec4.2.2}

The effects on PV are regionally dependent and hormone-specific ([@bib235]). By adulthood, females have more PV neurons in the amygdala and medial prefrontal cortex than males ([@bib215]; [@bib270]). ERβ receptors co-localize exclusively on PV neurons in layer V in PFC ([@bib23]; [@bib147]), with less expression of ERα on BDNF containing neurons ([@bib24]). Estrogen increases general neuronal loss between puberty (P35) and adulthood (P90) in the prefrontal cortex of rats ([@bib134]; [@bib166]). Pruning of synapses and PV are prevented by ovariectomy before puberty ([@bib272]). Intracellular androgen receptors are neither detected on PV neurons nor are PV neurons affected by gonadectomy in males; instead androgen receptors are predominantly localized to pyramidal cells in the PFC ([@bib146]). However, androgens predispose males to GABA-A mediated excitoxicity ([@bib193]).

4.3. Brain-derived growth factor (BDNF) {#sec4.3}
---------------------------------------

Changes in the methylation status of BDNF alter susceptibility to depression that is associated with early life stress ([@bib214]). DNA methylation of BDNF from the saliva BDNF changes in the human brain ([@bib232]). BDNF polymorphisms have been associated with increased risk for depression in individuals with a history of abuse ([@bib2]) and even more so if the serotonin transporter polymorphism is present. In animals, investigation into the ValMet polymorphism that decreases the effectiveness of BDNF interacts with sex and age and the type of stressor (reviewed in ([@bib13])). With a direct examination of rats that underwent maternal separation, changes in BDNF or its receptor, TrkB, correlate with depressive-like behavior ([@bib159]). Overall, exposure to maternal separation reduced levels of TrkB in the amygdala and the prelimbic prefrontal cortex were found in animals that had depressive-like behavior, but was elevated in behaviorally 'resilient' stressed rats. The elevation of TrkB levels discussed above could reflect a different group of rats that are resilient or an externalizing group. When maternal care was low during the first few days of life, amygdala BDNF levels showed early developmental decreases relative to controls ([@bib161]). We have recently found that mature BDNF analyzed from saliva reflects changes in prefrontal cortex BDNF levels of young adolescent, but not adult, animals ([@bib132]). Cortical BDNF in young adolescents correlates with increased reinstatement to cocaine, whereby low BDNF is associated with more cocaine intake ([@bib132]). Future studies may be able to track early BDNF changes by non-invasively collecting saliva.

4.4. Sensitive periods and their relationship to addiction {#sec4.4}
----------------------------------------------------------

The role that the neurochemistry of sensitive periods has relative to vulnerability to addiction is not well understood. The above discussion of the primary players (PV, BDNF/TrkB, and glutamate) have on opening and closing sensitive periods should be taken into account for future studies.

5. Reward reactivity, arousal, and inflammation as mediating factors in stress outcomes {#sec5}
=======================================================================================

5.1. Reward sensitivity and addiction {#sec5.1}
-------------------------------------

### 5.1.1. Clinical {#sec5.1.1}

Reactivity to reward is a moderating variable for depressive behavior in a maltreated population ([@bib63]). Exposure to early life stress markedly increases the risk for addiction to drugs of abuse ([@bib9]) in part by increasing reward insensitivity ([@bib202]). Reward insensitivity is found in both externalizing and internalizing disorders. Further, reward deficits are associated with increased aggression in humans ([@bib68]; [@bib88]).

Reduced salience in events that are normally rewarding could produce reward insensitivity. Reward salience is partially mediated by the dopamine D1 receptor in the prefrontal cortex. The *DRD1* gene is associated with behaviors found in conduct disorder: males show increased aggression ([@bib198]) and girls initiate sexual activity early and have more of it ([@bib181]). Childhood maltreatment is also common to both boys and girls with conduct disorder ([@bib76]; [@bib97]; [@bib137]) suggesting that early life experiences interact with the *DRD1* to elevate the risk of addiction in this population. The *DRD1* has been linked to aggression and sexual behavior ([@bib181]; [@bib198]).

### 5.1.2. Preclinical {#sec5.1.2}

A key characteristic of early life stress exposure in animal models is altered reward processing. Maladaptive social relationships and increased drug use following exposure to early adversity can be partially explained by a dysfunctional reward system. Social behavior is normally rewarding through its actions on the accumbens ([@bib104]; [@bib247]; [@bib255]). Under normal conditions, social interactions peak during adolescence before declining in adulthood ([@bib197]; [@bib203]; [@bib256]). Elevated offensive play is observed by juvenility in male separated rats, whereby these subjects show increases in nape attacks, offensive pulling and biting, with a decrease in submissive play ([@bib259]). By adulthood, exposure to maternal separation increases aggression compared with controls ([@bib109]).

We, and others ([@bib125]), suggest that transient over-expression of D1R in the cortex programs behavioral change to yield persistent changes into adulthood. Our data support the hypothesis that reduced reward function can be explained by a loss of D1 receptors on the prelimbic prefrontal cortex projections to the nucleus accumbens pathway in early life stress males ([@bib30]). Play studies using cortical microinjections ([@bib247]) or systemic D1 agonists/antagonists ([@bib96]) show D1 involvement. Therefore, less salience attributed to social relationships may explain reward insensitivity in individuals with an early life stress history. In contrast to this D1R reduction in separated males, the majority of glutamatergic projection neurons have elevated D1 receptors ([@bib32]). Increased prefrontal expression of the D1R increases sexual activity ([@bib92]), cocaine seeking, sensitivity, and motivation to take more cocaine ([@bib234]). Increased D1R expression is likely on prelimbic connections to the insula, amygdala and lateral hypothalamus amongst other regions ([@bib225]).

5.2. Arousal and addiction {#sec5.2}
--------------------------

### 5.2.1. Clinical cortisol {#sec5.2.1}

Child maltreatment has further been associated with long-term changes in hypothalamic---pituitary---adrenal (HPA) axis function ([@bib242]). Initial reports of elevated cortisol levels following maltreatment in adult women ([@bib114]) may be more reflective of the control group than maltreatment. The majority of studies in the last decade report decreased levels of cortisol in response to a stressor in individuals with a history of early life stress and externalizing symptoms and elevated cortisol in those with internalizing symptoms ([@bib47]; [@bib120]). Early life stress was associated with an earlier onset of puberty than controls and a blunted cortisol awakening response compared to lower early life stress ([@bib142]). The later onset of puberty predicted the opposite for cortisol responses.

While this suppression in responsiveness is an adaptive response to chronic stress exposure, low cortisol levels have been associated with increased addiction rates (reviewed by ([@bib230])) and aggressive behavior ([@bib89]; [@bib111]). Further, humans with antisocial behavior have low levels of cortisol and a greater risk for drug use ([@bib111]). Studies have shown that high maternal aggression in humans changes the testosterone-cortisol relationship from inverse (more testosterone, less cortisol) to positive in boys (more of both), and reduces the relationship in girls ([@bib229]). The former is a characteristic found in boys with conduct disorder.

### 5.2.2. Peripheral measures of stress and arousal {#sec5.2.2}

#### 5.2.2.1. Clinical {#sec5.2.2.1}

A well-established literature of arousal and motivation exists, whereby individuals are motivated to seek an optimal level of arousal (Yerkes-Dodson) and emotional arousal enhances perception of salient information; arousal also heightens the ability to learn ([@bib20]). While most research is focused on the effects of cortisol/corticosterone, measures of sympathetic arousal include galvanic skin response (GSR) and heart rate variability (HRV) that can be acquired non-invasively, which increases the likelihood of consent. More importantly, GSR and HRV are lower in a subgroup of children with high aggression ([@bib157]; [@bib162]; [@bib195]; [@bib209]) and in a subgroup of teens that are high-risk for substance use ([@bib252]). In other words, these children do not become aroused in the same way as normal children because their HRV is inversely related to aggression. Not surprisingly, children with low levels of early life stress in challenging situations may be insensitive to social cues or negative social consequences due to low arousal levels ([@bib98]). Low GSR reflects insensitivity to perceived negative consequences, which may underlie proactive aggression and antisocial behaviors ([@bib80]; [@bib219]).

### 5.2.3. Preclinical {#sec5.2.3}

Animals with an early stress history have reduced glucocorticoid ([@bib274]; [@bib274]) in (some), but not all, cases ([@bib65]; [@bib109]). However, elevated plasma levels of corticosterone have been reported ([@bib259]). Corticosterone administration at high physiological range for young rats (10 mg/kg i.p. between P2-20 ([@bib3]; [@bib275]) reduces PV levels in the hippocampus. The loss of synapses, in general, is similar to our observations with our maternal separation paradigm ([@bib29]; [@bib153]; [@bib160]). Reduced corticosterone levels produced by metyropone treatment (50 μg/g, ip 30 min) decreases over eating in maternally separated rats suggestive of metabolic effects as well ([@bib188]).

The effects of early life stress further interact with temperament. In studies examining rats bred for high or low novelty behavior, low novelty rats developed an exaggerated corticosterone response to challenge ([@bib52]). In contrast, high novelty rats show a blunted corticosterone response; these animals are also more aggressive. However, at this stage we do not know what influences arousal levels other than modulation by the dam ([@bib277]).

### 5.2.4. Gonadal hormones {#sec5.2.4}

An inverse relationship between corticosterone and gonadal hormones ([@bib75]) emerges during adolescence ([@bib66]) that may further explain increased aggression. As corticosterone falls, testosterone is predicted to rise. High maternal aggression in humans changes this testosterone-cortisol relationship to positive in boys, and reduces the relationship in girls ([@bib229]). For example, an inverse relationship between corticosterone and gonadal hormones emerges during adolescence normally ([@bib66]; [@bib75]).

5.3. Inflammation and addiction {#sec5.3}
-------------------------------

### 5.3.1. Immune effects {#sec5.3.1}

Elevated neuroimmune function has been found in individuals with addiction ([@bib56]; [@bib91]), depression ([@bib156]), schizophrenia ([@bib15]), PTSD ([@bib100]), exposure to adversity ([@bib41]; [@bib94]), and a host of other conditions. The elevated inflammation described in drug users is usually interpreted as secondary to the harmful effects of drug and alcohol use and have been expertly reviewed ([@bib55]; [@bib110]; [@bib148]). Here, we posit that a pre-existing condition of inflammation due to early life stress will increase the vulnerability to develop as substance use disorder ([@bib91]).

The immune system in the brain is comprised of astrocytes and microglia, both of which release proinflammatory cytokines. Initial studies showed that conditioned media derived from either of these cells reduced morphine and oxycodone place preferences ([@bib190]). Microglia and astrocytes express Toll-like receptors (TLRs). The TLR3, TLR4, TLR5, and TLR9 ([@bib84]). The TLRs are increased following exposure to alcohol ([@bib56]). Adolescent morphine exposure increases TLR4 on microglia within the nucleus accumbens ([@bib222]). Alcohol increased expression of the astrocytic marker, glial fibrillary acidic protein, has been described three weeks post exposure ([@bib27]). Increases in the proinflammatory molecule cyclooxygenase 2 (COX-2) or IL-6 are observed in maternally separated rats; these effects can be reduced with the anti-inflammatory agent IL-10 ([@bib31]). Exposure to early life stress will further enhance vulnerability to drugs of abuse by keeping the window of enhanced plasticity open.

Within a sensitive period framework, changes in neuroimmune function can influence developmental processes in three ways. First, normal synaptic pruning processes during maturation that are mediated by microglia ([@bib220]; [@bib221]) would be further increased following early life stress. During increased inflammation, microglial and other phagocytic markers engulf ∼30% of the cells ([@bib183]), which may further promote pruning. Microglia activation works in part by increasing intracellular calcium levels that lead to elevated secretion of IL-6, TNFα, and nitric oxide ([@bib83]). IL-6 has also been shown to elevate BDNF in hippocampal neurons ([@bib135]). In other words, these data suggest IL-6 could play a role in closing the sensitive period early, leaving PV in an immature, low state. The other two mechanisms involve glutamate and GABA, or the excitatory/inhibitory balance. Pro-inflammatory cytokines increase glutamate activity, decrease GABA receptors, and up-regulate AMPA/NMDA expression during opioid reward processes ([@bib128]). Elevated IL-6 levels are found in patients with depression ([@bib41]).

Second, cytokine-induced increases in glutamate activity would further alter plasticity by shifting the excitatory/inhibitory balance. Cytokine release increases glutamate levels by reducing the glutamate transporter 1 (GLT-1)/excitatory amino acid transporter-2 (EAAT2) and GLAST (glutamate and aspartate transporter), excitatory amino acid transporter-1 (EAAT1) (reviewed in ([@bib110])). We have found increased NR2a receptor expression in the prefrontal cortex of adolescent male rats exposed to maternal separation relative to controls ([@bib266]). Elevated NR2a has been observed following exposure to nicotine (rats ([@bib1]) and humans ([@bib262])), cocaine abstinence ([@bib18]), and prenatal alcohol ([@bib192]). Local microinjections of the anti-inflammatory cytokine IL-10 decrease the NR2a and have no effect in controls, showing neuroimmune involvement ([@bib266]).

Third, decreased inhibition by a loss of GABA cells would further elevate glutamate activity ([@bib29]; [@bib153]; [@bib160]). Parvalbumin neurons are decreased following exposure to maternal separation due to elevated levels of interleukin-6 (IL-6 ([@bib266]);). The source of IL-6 could be derived from the periphery, microglia ([@bib221]), or neurons themselves ([@bib150]). IL-6 has been shown to mark PV cells as "sick" for later demise ([@bib15]; [@bib71]). IL-6 is elevated in the plasma and prefrontal cortex of MS rats relative to control rats ([@bib266]), suggesting that these effects are locally mediated. Plasma levels of IL-1β have been reported to be elevated in MS males at P40 ([@bib266]), however, this effect was neither replicated in males nor found in females ([@bib106]). The brain cytokines, IL-1β and IL-2, can modulate rage either by acting through the 5-HT2 receptors or GABAA, respectively ([@bib227]).

### 5.3.2. Gonadal hormones {#sec5.3.2}

Microglia are affected by testosterone ([@bib95]), which is reduced in MS rats ([@bib106]). Decreased testosterone levels are associated with less anti-inflammatory IL-10, providing even less anti-inflammation protection in separated males. If GABA levels were to decrease and leave the neurons exposed to greater glutamate activity, both of which has been observed in MS rats ([@bib266]), then female microglia are likely to shift to the pro-inflammatory (M1) state more so than males ([@bib221]).

6. Prevention approaches {#sec6}
========================

6.1. Timing of intervention {#sec6.1}
---------------------------

During human adolescence the trajectories between individuals exposed and not exposed to early life stress diverge. Abused and non-abused children begin to separate in developmental trajectories at \<11 years of age ([@bib264]), before the onset of puberty. Evidence for a delay in the manifestation of early life stress exists in both humans ([@bib243]) and in animals ([@bib8]; [@bib30]). Adolescence is also the stage when elevated amygdala activity is observed in children with an early life stress history ([@bib163]; [@bib168]).

While early stress exposure increases vulnerability, it also important to recognize that this same interaction may also underlie the ideal timing for a preventative intervention ([@bib10]; [@bib173]). In both humans and animals, reduced hippocampal volume is associated with early life stress, whereas prefrontal changes are associated with adolescent stress ([@bib8]; [@bib10]; [@bib11]); adolescence is also the stage when changes associated with early stress exposure become evident ([@bib29]). If stress exposure can accelerate the emergence of depression ([@bib243]; [@bib264]), it is likely that stress will accelerate the initiation of drug use ([@bib129]). Earlier initiation is associated with greater duration of addiction ([@bib174]; [@bib261]). One likely reason for this elevated vulnerability is due to the specificity of stress exposure on unique regions during a sensitive period ([@bib11]).

6.2. Social buffering {#sec6.2}
---------------------

Reinforced, positive social behavior influences later behavior by shaping the development of the prefrontal cortex to respond to social cues ([@bib16], [@bib17]), increase behavioral flexibility ([@bib119], [@bib118]), and modulate physiologic responsiveness ([@bib122]). Other brain regions also play a role in this process, but are likely to receive activity from the prelimbic cortex to influence the behavioral outcome. Evidence of the impact of social interaction on vulnerability to mental illness, addiction, or even neuroimmune challenge is observed at the clinical and preclinical level.

Differences in parenting styles support this position. The Romanian orphan study is a superb example of how children with a significant history of early life stress ([@bib131]) show low cortisol levels, ADHD, and peer difficulties and have fewer problems when placed into foster home ([@bib205]). Rodent studies have shown that different levels of social buffering are evident in differences in maternal care. Differences in high/low-LG dams (reviewed above) or under experimental conditions of low maternal care found in the maternal separation paradigm or communal nesting ([@bib161]) reduces social interaction later in life ([@bib259]). Modulation of passive behavior demonstrated by guinea pigs in the absence of the mother can be remediated by the presence of the dam and mimicked by lipopolysaccharide (a challenge that engages an immune response) ([@bib115]). The dam further buffers maternal separation effects on sexual behavior ([@bib208]).

Peer support is also important, especially during adolescence. Social isolation during this time is associated with greater depression, drug use, internet use, and other disruptive behaviors in humans ([@bib77]; [@bib191]) and in animals ([@bib74]; [@bib152]; [@bib184]). The loss of peer support in rats is associated with more anhedonic behavior and corticosterone, although these effects are reduced in rats with a maternal separation history ([@bib22]; [@bib160]).

6.3. Existing pharmacotherapies {#sec6.3}
-------------------------------

Prevention is already possible with medications that are currently available when their use is optimally timed. Enduring reductions in substance use are found in adolescents who were treated in childhood in a subpopulation of individuals with ADHD ([@bib164], [@bib165]; [@bib172]; [@bib267]). However, not all studies, including the Multimodal Treatment of ADHD study, observe an overall reduction in drug use after treatment ([@bib113]; [@bib121]). Animal studies support the findings that preventative effects depend on timing. Juvenile exposure to methylphenidate in rats (P20-35) produces an aversion to cocaine-associated environments. In contrast, post-pubertal exposure (P50-65) produces a place preference for cocaine ([@bib7]). Cocaine self-administration is reduced following methylphenidate treatment from P30-240 ([@bib245]) and is increased in animals exposed later to methylphenidate (P35-60 ([@bib28]);) or earlier ([@bib54]).

6.4. Novel pharmacotherapies {#sec6.4}
----------------------------

Preventative interventions to reduce the effects of early life stress on brain development should capitalize on a sensitive period of development for its timing and its biological basis. In human ([@bib244], [@bib243]) and in animal studies, early life stress exposure does not manifest until adolescence (reviewed ([@bib10])). Treatment prior to the emergence of symptoms therefore would be aimed at reducing inflammation, decreasing glutamate activity, or increasing GABA/PV and/or BDNF levels. An intervention with COX-2 inhibitor (an anti-inflammatory) reduces elevated COX-2 levels and IL-6 in maternally separated animals ([@bib29]). Exposure to a COX-2 inhibition reduced stress-induced working memory impairment ([@bib29]) and depressive-like behavior ([@bib160]). Anti-inflammatory treatment can reduce depressive-like behaviors ([@bib29]; [@bib116]; Lukkes et al.; [@bib239]). Exposure to a probiotic diet would also decrease inflammation ([@bib61]). Probiotics would also aid in sleep and social interaction because of feeling better.

Also within a sensitive period manipulation, increasing BDNF levels by antidepressants ([@bib72]; [@bib226]) can provide some degree of improvement. Finally, reducing glutamatergic activity with treatment with adinazolam and MK-801, but not by augmenting serotonin activity with tianeptine ([@bib154]) was shown to reduce the effects of a social stressor in rats (see [Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}).Fig. 1The outcomes of early life stress exposure on behavior. The arrows represent the prevalence of gender effects (pink for females, blue for males) for internalizing and externalizing disorders. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 1Fig. 2The mediating and moderating variables of the outcomes of early life stress exposure. These factors interact with sensitive periods of brain development (color picture shows the progressive pruning processes in the brain ([@bib101])) by altering levels of parvalbumin (PV), BDNF and its receptor TrkB, and glutamate levels to shape the adult brain. The behavioral outcomes of internalizing and externalizing disorders increase the vulnerability to develop addiction. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 2

7. Conclusions {#sec7}
==============

Early life stress exposure interacts with sensitive periods of development to permanently alter the trajectory of behavior and biochemistry. Exposure to stress early in postnatal life is associated with an accelerated age of onset for drug use, but also greater vulnerability to addiction. A number of moderating and mediating factors are discussed. The factors of arousal levels, inflammation, and the timing of stress exposure influence the outcome of early life adversity. By carefully timed interventions we may be able to prevent the cascade of adverse consequences of child maltreatment.
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